Blockchain circle

One stop hot information platform

About us:

Blockchain circle provides the latest information about blockchain, digital currency, digital wallet, exchange, metauniverse, bitcoin, Ethereum, contract, financial management and so on, and always pays attention to the latest market...

What are the concept stocks in the lithium fluoride sector (202282)

Time : 20/06/2021 Author : sce5k4 Click : + -
        According to the quarterly report of the first quarter of 2022, Ganfeng lithium achieved a revenue of 5.365 billion yuan, an increase of 233.91% year-on-year; The net profit was 3.103 billion yuan, and the net interest rate was 66.35%. The company is engaged in the production of lithium deep-processing series products, covering more than 20 kinds of lithium series products, such as lithium metal (industrial grade, battery grade), lithium carbonate (battery grade), lithium chloride (industrial grade, catalyst grade), butyl lithium, lithium fluoride (industrial grade, battery grade), etc. it is a professional manufacturer with the most complete variety of lithium series products, the longest product processing chain, and the most comprehensive process technology in China. Lithium metal, lithium carbonate and lithium fluoride are the main products of the company.
 
        In December 2012, the company plans to acquire 49% equity of youpai new energy with no more than 6.7815 million yuan, and will realize full control with the transfer of 51% equity of youpai new energy with 20.4 million yuan in June 2011. The company is mainly engaged in power batteries, lithium-ion batteries, etc., and has the core technology for the production of ternary cathode material precursors of lithium batteries and other lithium battery cathode material technologies. The ternary cathode material precursors of lithium batteries and battery grade lithium carbonate produced by Ganfeng lithium industry are the two main raw materials of lithium battery anode materials. In the past five days, Ganfeng lithium's share price fell by 6.47%, and its total market value fell by 11.49 billion, with the current market value of 177.57 billion yuan.
 
        The share price fell -53.52% in 2022. Yongtai Technology: Yongtai technology showed in the first quarter of 2022 that the company achieved a revenue of 1.737 billion yuan, a year-on-year increase of 103.75%; The net profit was 381million yuan, and the net interest rate was 24.95%. The existing capacity is 2000 tons. The company said on the investor interaction platform on May 14 that the project with an annual output of 6000 tons of lithium hexafluorophosphate and 1500 tons of lithium difluorosulfonate and supporting lithium fluoride is under construction. At present, it is progressing smoothly, and the time of reaching production is determined according to the progress of the project. Looking back on the past five trading days, Yongtai technology fell for three days. During the period, the overall decline was 5.05%, the highest price was 32.9 yuan, the lowest price was 31.58 yuan, and the total trading volume was 177million hands.
 
        DOVID: according to the quarterly report of the first quarter of 2022, the company achieved a total revenue of 2.654 billion yuan, an increase of 112.89% year-on-year; The gross profit was 1.13 billion yuan and the net profit was 741 million yuan. Focusing on the research and development of the three elements of "fluorine, lithium and silicon", the company studies the synthesis of new materials from the perspective of lean chemical industry, divides fluorine and silicon, combines fluorine and lithium, uses fluorine as the by-product of phosphate fertilizer to produce polymer cryolite, and silicon as the by-product to produce silica and monocrystalline silicon, and has made new breakthroughs in the research and development of lithium resources. Through the purification of lithium concentrate, the by-product lithium fluoride can be sold out and lithium containing anhydrous aluminum fluoride can be produced, Further reduce the manufacturing cost of lithium hexafluorophosphate and realize the high-end utilization of low-grade lithium resources.
 
        In the past five trading days, doxorubicin fell for three days, with an overall decline of 8.18% during the period. Compared with five trading days ago, the market value of doxorubicin fell by 2.949 billion yuan, or 8.18%. Tianji shares: the quarterly report of Tianji shares in the first quarter of 2022 shows that the company achieved a total revenue of 1.002 billion yuan, an increase of 260.37% year-on-year; The gross profit is 558million yuan and the net profit is 411 million yuan. It is proposed to raise no more than 2.11 billion yuan for 30000 tons of lithium hexafluorophosphate, 6000 tons of high-purity lithium fluoride and other new electrolyte lithium salts and integrated supporting projects of Jiangsu Teri LIANTENG Material Technology Co., Ltd.
 
        In the past five days, the share price of Tianji shares fell by 6.55%, and the total market value fell by 597million yuan, with the current market value of 9.237 billion yuan. The share price fell -29.01% in 2022. Statement: all articles and data on this website are for reference only. No one shall use it for illegal purposes, otherwise he shall bear the responsibility. The advertisements on this website are the personal opinions and expressions of advertisers,. It has nothing to do with this website. Linked advertisements shall not violate national laws and regulations. If they do, this website has the right to delete them at any time, and reserves the right to cooperate with relevant departments to investigate. It is hereby declared that the words and actions of advertisers have nothing to do with southern fortune.
 
        
Previous:The collective departure of senior executives and the three limit decline of stocks... The easy-to-see shares of Yunnan "blockchain leading stocks" were filed for investigation
Next:No more

Related articles:



© 2005-2032 | Blockchain Circle & & All Rights Reserved    Sitemap1 Sitemap2 If there is infringement, please contact us at: